Evan A. Thackaberry

Corporate Officer/Principal bei VIGIL NEUROSCIENCE, INC.

Vermögen: 4 770 $ am 31.05.2024

51 Jahre

Health Technology

Consumer Services

Aktive Positionen von Evan A. Thackaberry

Unternehmen	Position	Beginn	Ende
VIGIL NEUROSCIENCE, INC.	Corporate Officer/Principal	01.09.2020	-

Unternehmen	Position	Beginn	Ende
RA PHARMACEUTICALS, INC.	Corporate Officer/Principal	01.10.2017	01.03.2020

University of Wisconsin

Doctorate Degree

International

Vereinigte Staaten

Operativ

Corporate Officer/Principal	2
Doctorate Degree	1

Sektoral

Health Technology	3
Consumer Services	2

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	1
VIGIL NEUROSCIENCE, INC.	Health Technology

Private Unternehmen	1
Ra Pharmaceuticals, Inc. Ra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ra Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of peptide-based drugs. It uses Extreme Diversity platform that allows to produce synthetic macrocyclic peptides. The company was founded by James W. Broderick and Douglas A. Treco on June 27, 2008 and is headquartered in Cambridge, MA.	Health Technology

Private Unternehmen

Health Technology